Cigna Corporation (CI) Return on Equity (ROE): 14.90%
Is Cigna Corporation’s return on equity (ROE) high or low?
Cigna Corporation's return on equity (ROE) of 14.90% is 16% above its 5-year average of 12.83%, near the high end of its 5-year range (8.37%–16.81%).
The return on equity (ROE) for Cigna Corporation (CI) is 14.90% as of Wednesday, June 10, 2026. It is above its 12-month average by 31.57% (11.32%).
CI Return on Equity (ROE) Chart
CI Average Return on Equity (ROE) Chart
CI Current vs Average Return on Equity (ROE) Chart
CI Return on Equity (ROE) Metrics
RETURN ON EQUITY (ROE)
14.90%
RETURN ON EQUITY (ROE) AVG TTM
11.32%
RETURN ON EQUITY (ROE) AVG 3Y
12.19%
RETURN ON EQUITY (ROE) AVG 5Y
12.83%
RETURN ON EQUITY (ROE) AVG 10Y
12.90%
RETURN ON EQUITY (ROE) AVG 15Y
14.15%
RETURN ON EQUITY (ROE) AVG 20Y
16.14%
CURRENT VS TTM AVG
+31.57%
CURRENT VS 3Y AVG
+22.23%
CURRENT VS 5Y AVG
+16.15%
CURRENT VS 10Y AVG
+15.46%
CURRENT VS 15Y AVG
+5.31%
CURRENT VS 20Y AVG
-7.71%
CI Competitors' Return on Equity (ROE)
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cigna Corporation (CI) | $78.25B | 14.90% | 11.32% | 12.19% | 12.83% |
| Elevance Health Inc. (ELV) | $87.43B | 11.94% | 13.69% | 14.71% | 14.93% |
| Regeneron Pharmaceuticals, Inc. (REGN) | $62.59B | 14.08% | 14.72% | 15.95% | 23.11% |
| Medtronic plc (MDT) | $103.04B | 9.80% | 4.86% | 6.08% | 6.82% |
| Vertex Pharmaceuticals Incorporated (VRTX) | $110.77B | 22.41% | 8.96% | 15.60% | 19.47% |
| IDEXX Laboratories, Inc. (IDXX) | $44.47B | 70.38% | 60.82% | 72.53% | 81.69% |
| Humana Inc. (HUM) | $43.78B | 6.08% | 7.05% | 11.93% | 15.09% |
| Bristol-Myers Squibb Company (BMY) | $114.14B | 36.25% | -8.30% | 7.76% | 4.45% |
| Agilent Technologies, Inc. (A) | $37.17B | 19.85% | 20.59% | 21.51% | 20.54% |
| Zoetis Inc. (ZTS) | $34.20B | 81.75% | 66.19% | 56.82% | 52.60% |
Return Analysis
ROE
14.9%
ROA
4.1%
Cigna Corporation Return on Equity (ROE) Formula & Definition
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Cigna Corporation Return on Equity (ROE) FAQ
- What is the return on equity (ROE) for Cigna Corporation (CI)?
- The return on equity (ROE) for CI stock is 14.90%.
- Is Cigna Corporation's return on equity (ROE) high or low?
- Cigna Corporation's return on equity (ROE) of 14.90% is 16% above its 5-year average of 12.83%, near the high end of its 5-year range (8.37%–16.81%).
- What is the TTM average return on equity (ROE) for Cigna Corporation (CI)?
- The TTM average return on equity (ROE) for CI stock is 11.32%.
- What is the 3Y average return on equity (ROE) for Cigna Corporation (CI)?
- The 3Y average return on equity (ROE) for CI stock is 12.19%.
- What is the 5Y average return on equity (ROE) for Cigna Corporation (CI)?
- The 5Y average return on equity (ROE) for CI stock is 12.83%.
- What is the 10Y average return on equity (ROE) for Cigna Corporation (CI)?
- The 10Y average return on equity (ROE) for CI stock is 12.90%.
- What is the 15Y average return on equity (ROE) for Cigna Corporation (CI)?
- The 15Y average return on equity (ROE) for CI stock is 14.15%.
- What is the 20Y average return on equity (ROE) for Cigna Corporation (CI)?
- The 20Y average return on equity (ROE) for CI stock is 16.14%.
Cigna Corporation Return on Equity (ROE) History
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2025-12-31 | 14.28% |
| 2024-12-31 | 8.37% |
| 2023-12-31 | 11.17% |
| 2022-12-31 | 14.94% |
| 2021-12-31 | 11.40% |
| 2020-12-31 | 16.81% |
| 2019-12-31 | 11.26% |
| 2018-12-31 | 6.43% |
| 2017-12-31 | 16.29% |
| 2016-12-31 | 13.60% |
| 2015-12-31 | 17.40% |
| 2014-12-31 | 19.51% |
| 2013-12-31 | 13.97% |
| 2012-12-31 | 16.61% |
| 2011-12-31 | 15.10% |
| 2010-12-31 | 19.25% |
| 2009-12-31 | 24.04% |
| 2008-12-31 | 8.13% |
| 2007-12-31 | 23.48% |
| 2006-12-31 | 26.67% |
| 2005-12-31 | 30.32% |
| 2004-12-31 | 27.64% |
| 2003-12-31 | 13.99% |
| 2002-12-31 | -11.56% |
| 2001-12-31 | 18.58% |
| 2000-12-31 | 17.46% |
| 1999-12-31 | 28.85% |
| 1998-12-31 | 15.61% |
| 1997-12-31 | 13.69% |
| 1996-12-31 | 14.65% |
Related Metrics
About Cigna Corporation
Cigna Group, established in 1792 and headquartered in Bloomfield, Connecticut, provides insurance products and related services across the United States. The company operates through two primary segments. Its Evernorth division offers a comprehensive array of coordinated and specialized health solutions, including pharmacy services, benefits administration, care management and delivery, and advanced intelligence solutions. These offerings cater to a diverse clientele, such as health plans, employers, government entities, and healthcare providers. Meanwhile, the Cigna Healthcare segment delivers an extensive portfolio of products and services, encompassing medical, pharmaceutical, behavioral health, dental, vision, and health advocacy programs for both insured and self-insured customers. This segment also provides Medicare Advantage, Medicare Supplement, and Medicare Part D plans specifically for seniors, in addition to individual health insurance options available on and off public exchanges. Globally, Cigna Healthcare extends international health coverage and benefits to mobile professionals and employees of multinational organizations. Furthermore, the company issues permanent insurance contracts to corporations, designed to cover the lives of specific employees for funding future benefit obligations. Cigna distributes its various offerings through insurance brokers and consultants, direct sales channels to employers, unions, and individuals, and via both private and public exchanges.
- Sector
- Healthcare
- Industry
- Medical - Healthcare Plans
- CEO
- David Michael Cordani